Biotechnology
Healthcare
Investing News
Life Style
Market News
Medical Use
Pharmaceutical
Products
Technology
The Market Buzz
Your Environment
Biogen Receives FDA Approval for Alzheimer’s Drug
On Monday, The Food and Drug Administration, approved Biogen’s (NASDAQ: BIIB) Alzheimer’s disease drug aducanumab. The medication, which delays the cognitive decline in patients with Alzheimer’s, is the first...